Edition:
United States

Paion AG (PA8G.DE)

PA8G.DE on Xetra

2.32EUR
16 Jan 2019
Change (% chg)

€-0.03 (-1.28%)
Prev Close
€2.35
Open
€2.32
Day's High
€2.35
Day's Low
€2.30
Volume
76,891
Avg. Vol
46,448
52-wk High
€2.72
52-wk Low
€1.91

Chart for

About

Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In... (more)

Overall

Beta: 0.47
Market Cap(Mil.): €155.18
Shares Outstanding(Mil.): 63.86
Dividend: --
Yield (%): --

Financials

  PA8G.DE Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.20 -- --
ROI: -52.48 0.60 13.80
ROE: -52.48 -2.18 15.29

Earnings vs. Estimates